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It is with much sadness that we record the untimely death of 
Professor Velo at the young age of 74 years. He was a foun-
dation editor of Inlammopharmacology specializing in the 
clinical pharmacology and epidemiology of NSAIDs, espe-
cially in relation to adverse drug reactions, of which he was 
an internationally-recognized and highly regarded expert.
Giampaolo and I organized several international confer-
ences in Verona (IT), Cambridge (UK) and Milano (IT) 
on “Side Efects of Anti-inlammatory Analgesic Drugs”. 
(Refer to “Conferences”). It was always a great pleasure to 
work on organizing these meetings with Giampaolo. He had 
a great ability to create programmes, liaise with speakers 
and sponsors and was a great help in organizing the venues 
in Italy and running the meetings as co-chairman. For this 
support and help in obtaining highly favourable outcomes 
that enjoyed wide support and recognition, as well as several 
successful book publications (Refer “Conference Publica-
tions”) and for his encouragement and enthusiastic support, 
I am immensely grateful.
Conference proceedings
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Giampaolo Velo showing geniality at a conference in 
Prague a decade or so ago, surrounded by friends who nat-
urally gravitated to him
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Conference details and publication of proceedings
1. Side-Efects of Anti-inlammatory/Analgesic Drugs
(K.D. Rainsford and G.P. Velo, Organisers), September 1982
Publication, Book: Side-Efects of Anti-inlammatory/Analgesic 
Drugs. Advances in inlammation research, 6
Editors: K.D. Rainsford and G.P. Velo. Raven Press, New York, 1984
2. Side-Efects of Anti-Inlammatory Drugs
(K.D. Rainsford and G.P. Velo, Organisers)
Venue: University of Cambridge & Queens’ College, Cambridge 
(UK) 31st July to 2nd August. 1985
Publication, Book: Side-Efects of Anti-Inlammatory Drugs, 2 Part 
Volumes
Editors: K.D. Rainsford and G.P. Velo. MTP Press, Lancaster, 1985
3. Side-Efects of Anti-Inlammatory Drugs
(K.D. Rainsford and G.P. Velo, Organisers)
Venue: University of Verona (Italy), 8th–11 May, 1991
Publication/Book: Side-Efects of Anti-inlammatory Drugs, 3
Editors: K.D. Rainsford and G.P. Velo. Kluwer Academic Publishers, 
Lancaster, 1992
4. Side-Efects of Anti-Inlammatory Drugs
(K.D. Rainsford, Organiser)
Venue: Sheield Hallam University, 7th–9th August, 1995
Publication/Book: Side-Efects of Anti-Inlammatory Drugs, IV
Editors: K.D. Rainsford and G.P. Velo. Kluwer Academic Publishers, 
Dordrecht, 1997
Publication (peer-review papers): Inlammopharmacology, Vol 3, pp 
137-204 and 311-399, 1996
One of Giampaolo’s many personal attributes was his engag-
ing and charming personality. He had an insightful human 
understanding, was much admired and literally “loved by 
all”. In these and so many ways he will be very sadly missed.
Giampaolo was born in Padova (Italy), and studied medicine 
and surgery at the University of Bologna from which he 
graduated in 1967. From 1969, he was appointed to several 
university posts at professorial assistant level at the Universi-
ties of Bologna-Padova (Verona). In 1986 he was appointed 
full Professor in Pharmacology at the University of Verona 
and in 1977–1999 was appointed Director of the Institute of 
Pharmacology of the University of Padova (Verona) and the 
University of Verona. It was at the beginning of this appoint-
ment that I irst met Giampaolo, initially at a conference 
on Anti-inlammatory Drugs in Pisa organized by Profes-
sor Bertelli. Following this I frequently visited Giampaolo 
in his spacious institute. Entering his palatial oice was a 
great experience—tall ceilings, grand photographs of his 
eminence and other great items among the grand furniture. 
He was supported by a remarkable secretary and had a busy 
team of research assistants and colleagues that gave the insti-
tute a sense of buzz and productivity. One of his valued 
research collaborators, was the late Dr. Roberto Milanino 
(Obituary, in Inlammopharmacology 2008;16:103–105), 
whose work on trace metal influences in inflammation 
has been regarded as fundamental to the understanding of 
the association of the efects of copper and zinc in exper-
imentally-induced and clinically-important inlammatory 
conditions. Other studies on the anti-inlammatory activity 
of copper complexes included some novel ligands which 
were developed by other colleagues (chemists).
During the early 1970s Giampaolo worked at St. Bartho-
lomew’s Hospital, London, with Professor Derek Wil-
loughby (Obituary, in Inflammopharmacology 2005; 
12:407–439). Their work involved animal studies of the 
effects of anti-inflammatory drugs on experimentally-
induced inlammatory conditions. For this he received fund-
ing from the Wellcome Trust and NATO; later Giampaolo 
was to receive generous funding from NATO for organizing 
advanced teaching conferences on the science of inlamma-
tion and actions of anti-inlammatory drugs. These confer-
ences were mostly held in Sicily and had wide support.
Giampaolo was a natural networker, an ability he combined 
with great charm. As he progressed from research on experi-
mental pharmacology of inlammation, Giampaolo recog-
nized the increasing concerns about the safety, or lack of it, 
of anti-inlammatory analgesics. For this, his involvement 
with agencies at the national (Veneto Region), Pan-European 
and WHO-Uppsala levels, led to his recognition as a leading 
international authority on the occurrence and developments 
of adverse drug reactions (ADR). Among major appoint-
ments, he was an executive member of the European Society 
of Pharmacovigilance (EOSP; 1998–2000), a founder mem-
ber and Chairman of the European Association for Clinical 
Pharmacology and Therapeutics (EACPT; 1999–2003) and 
President of the International Society of Pharmacovigilance 
(ISoP; 2003–2006).
These involvements led him to be critical and charac-
teristically conservative about ADR assessments, while 
managing to avoid political pitfalls especially when in an 
advisory role. His integrity on these aspects was widely 
recognized.
In more recent years, Giampaolo became interested in the 
problems of accumulation of pharmaceuticals and their man-
ufacturing intermediates and metabolites in the environment, 
especially in surface water supplies.
Thus, in summary the contributions of Professor Giampaolo 
Velo to pharmacology; are that he started from the basic 
sciences, and achieved outstanding recognition for his work 
on pharma-epidemiology and drug safety monitoring. The 
breadth of his interests and depth of enquiries was very 
impressive.
He leaves his wife, Giulia, and three children, to whom he 
was much devoted. He was undoubtedly a very kind, hospi-
table and generous person to all.
Publications—Giampaolo Velo
Viola E, Magro L, Verlato G, Finocchio E, Leone R, Velo 
GP. (2016) A project on adverse drug reactions due to med-
ication errors in hospital. Drug Safety 39(10):1025–1025 
(Abstract P072).
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Arzenton E, Paon V, Leone R, Apostoli P, Conforti A, Capra 
F, Velo GP. (2012) Acute hepatitis caused by green tea infu-
sion: a case report. Drug Safety 35(10):944–944.
Moretti U, Lora R, Zanoni G, Tartaglia L, Ferrazin F, Velo 
GP, Santuccio C. (2011) Impact of non-vaccine-related 
reports on statistical signal detection for vaccines in spon-
taneous reporting databases. Drug Safety 34(10):926–926.
Leone R, Magro L, D’incau P, Minuz P, Paluanl F, Nuvolari 
R, Bonaini S, Velo GP. (2011) A pilot prospective observa-
tional hospital study on adverse drug reactions due to medi-
cation errors. Drug Safety 34(10):953–954.
Lindquist M, Velo GP. (2010) Erice statement 2009: com-
munication, medicines and patient safety. Br J Clin Pharma-
col 69(2):207–208.
Opri S, Leone R, Moretti U, Conforti A, D’Incau P, Magro L, 
Smerghetto M, Velo GP. (2010) Adverse events and adverse 
drug reactions in hospital observed by nurses: prospective 
analysis of 4608 patients. Drug Safety 33(10):922–923 
(Abstract 70).
Costantini D, Leone R, Zanetti F, Grezzana M, Moretti U, 
Conforti A, Donati M, Velo GP. (2010) Adverse drug reac-
tions in Italian geriatric wards. Drug Safety 33(10):923–923 
(Abstract 71).
Velo GP, Minuz P. (2009) Medication errors: prescrib-
ing faults and prescription errors. Br J Clin Pharmacol 
67(6):624–628.
Conforti A, Magro L, Costantini D, Opri S, Santuccio C, 
Venegoni M, Moretti U, Leone R, Velo GP. (2009) Haemato-
logical reactions by vaccines: data from the Italian spontane-
ous reporting system. Drug Safety 32(10):927–927 (Abstract 
122).
Velo GP, Costantini D, Donati M, Opri S, Moretti U, Santuc-
cio C, Venegoni M. (2009) NSAID use and safety in Italy: 
variation after the change of the supply status of nimesulide. 
Drug Safety 32(10):928–928 (Abstract 124).
Velo GP, Minuz P (2009). Medication errors: prescrib-
ing faults and prescription errors. Br J Clin Pharmacol 
67(6):624–628.
Apolone G, Bassi M, Begaud B, Cascorbi I, Chiamulera C, 
Dodoo A, Ferro L, Ghignoni G, Isola G Juillet Y, Masotti G, 
Novelli G, Rizzini P, Russo P, Silano V, Tricarico G, Velo 
GP. (2008) Erice statement on drug innovation. Br J Clin 
Pharmacol (3):440–441.
Leone R, Moretti U, Conforti A, Magro L, Moschini M, 
Tuccori M, Cutroneo P, Motola D, Velo GP. (2008) Detect-
ing adverse drug reactions caused by drug–drug interac-
tion in a spontaneous reporting database. Drug Safety 
31(10):938–938 (Abstract 140).
Apolone G, Bassi M, Begaud B, Cascorbi I, Ferro I, Ghi-
gnoni G, Isola G, Juillet Y, Masotti G, Russo P, Silano V, 
Tricarico G, Velo GP (2008) Erice statement on drug inno-
vation. Br J Clin Pharmacol 65:440–441.
Velo GP, Motola D, Vargiu A, Magro L, Meneghelli I, Vac-
cheri A, Conforti A, Montanaro N. (2007) The inluence 
of notoriety bias on ADR spontaneous reporting rate. Drug 
Safety 30(10):925–925.
Velo GP. (2007) Why ecopharmacovigilance? Drug Safety 
30(10):932–932.
Meneghelli I, Biogi C, Iorio ML, Salvo F, Scotto S, Testi A, 
Velo GP. (2007) Toxicity proile of ticlopidine: unavoidable 
reactions? Drug Safety 30(10):952–953.
Depont F, Fourrier A, Merlière Y, Droz C, Amouretti M, 
Bégaud B, Bénichou J, Moride Y, Velo GP, Sturkenboom 
M, Blin P, Moore N; CADEUS Team (2007). Channelling 
of COX-2 inhibitors to patients at higher gastrointestinal risk 
but not at lower cardiovascular risk: the COX2 inhibitors 
and tNSAIDs description of users (CADEUS) study. Phar-
macoepidemiol Drug Safety 16(8):891–900.
Iorio ML, Moretti U, Colcera S, Magro L, Meneghelli I, 
Motola D, Rivolta AL, Salvo F, Velo GP (2007). Use and 
safety proile of antiepileptic drugs in Italy. Eur J Clin Phar-
macol. 63(4):409–415.
Leone R, Colcera S, Venegoni M, Caputi A, Conforti A, 
Magro L, Meneghelli I, Cocci A, Vargiu A, Velo GP. (2006) 
Drug-related deaths: analysis of an Italian spontaneous 
reporting database. Drug Saf 29(10):944–944 (Abstract 62).
Motola D, Vargiu A, Leone R, Moretti U, Scotto S, Cutroneo 
PM, Ros B, Velo GP, Montanaro N. (2006) Hepatic adverse 
drug reactions: analysis of an Italian spontaneous reporting 
database. Drug Saf 29(10):954–954 (Abstract 82).
Moretti U, Iorio ML, Colcera S, Passiu M, Meneghe-
lli I, Salvo F, Motola D, De Bastiani E, Velo GP. (2006) 
Use and safety profile of antiepileptic drugs. Drug 
Safety 29(10):1003–1003 (Abstract 180).
Eland IA, Sundström A, Velo GP, Andersen M, Sturken-
boom MC, Langman MJ, Stricker BH, Wiholm B; EDIP 
Study Group of the European Pharmacovigilance Research 
Group (2006). Antihypertensive medication and the risk 
of acute pancreatitis: the European case–control study on 
drug-induced acute pancreatitis (EDIP). Scan J Gastroen-
terol 41(12):1484–1490.
Cataldi L, Fanos V, Benini D, Riccobene F, De Mitri B, Rug-
geri L, Pinna B, Sabatino G, Torcasio F, Attardo G, Tonetto 
P, Ziccardi MR, Zanardo V, Borgione M, Benini D, Perin 
M, Martano C, Velo GP. (2005) Drugs, therapeutic inter-
ventions, diseases and renal function in preterm newborn 
infants. A multicenter study. Pediatric Res 58(2):365–365 
(Abstract 64).
Velo GP, Magro L, Cocci A, Dusi G, Ros B, Salvo F, Leone 
R. (2005) Statins and hepatic reactions: data from spontane-
ous reporting in Italy. Drug Safety 28(10):960–961 (Abstract 
85).
Velo GP, Colcera S, Scotto S, Motola D, Caputi A, Con-
forti A. (2005) Musculoskeletal adverse drug reactions: 
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Data from spontaneous reporting database in Italy. Drug 
Safety 28(10):961–962 (Abstract 87).
Velo GP, Meneghelli I, Zuliani V, Montanaro N, Venegoni 
M, Moretti U. (2005) Adverse drug reactions by systemic 
anti-bacterials: signals from spontaneous reporting in Italy. 
Drug Safety 28(10):961–961 (Abstract 86).
Conforti A, Magro L, Kiuru A, Velo GP, Strandell J. (2004) 
Ciclosporin and serious intestinal disorders. Drug Safety 
27(12):924–924.
Leone R, Meneghelli I, Camerlengo T, Segat S, Moretti U, 
Velo GP. (2004) Domestic self-medication: an Italian atti-
tudinal survey. Drug Safety 27(12) 943–944.
Leone R, Conforti A, Ghiotto E, Moretti U, Valvo E, Velo 
GP (1999). Nimesulide and renal impairment. Eur J Clin 
Pharmacol 55(2):151–154.
Belton KJ, Gram LF, Royer RJ, Feely J, McGettigan P, Velo 
GP, Conforti A, Leone R, Stricker BHC, Teixeira F, Laporte 
JP, Capella D, Beermann B, Lewis SC, Payne S, Rawlins 
MD, Wood SM. (1997) Attitude survey of adverse drug-
reaction reporting by health care professionals across the 
European Union. Eur J Clin Pharmacol 52(6):423–427.
Franco L, Velo GP (1996). A copper-complex reduced gas-
tric damage caused by acetylsalicylic acid and ethanol. 
Prostaglandins 51(5):331–338.
Pasqualicchio M, Gasperini R, Velo GP, Davies ME 
(1996). Effects of copper and zinc on proteoglycan 
metabolism in articular cartilage. Mediators Inlamm. 
5(2):95–99.
Franco L, Cavallini G, Bovo P, Marcori M, Orlandi PG, 
Moltrer F, Vetturi B, Velo GP (1995). Gastric eicosanoid 
synthesis in normal subjects and alcoholics after ethanol 
stimulation. Ital J Gastroenterol 27(5):244–247.
Franco L, Velo GP (1995). Eicosanoid and gastropro-
tection by copper derivatives and NDGA. Inflamm Res 
44(3):139–142.
Guglielmo L, Leone R, Moretti U, Conforti A, Velo GP 
(1994). Antimicrobial drug utilisation in hospitals in 
Italy and other European countries. Infection 22 Suppl 
3:S176–S181.
Guglielmo L, Leone R, Moretti U, Conforti A, Velo GP, 
Vespignani S, Zappala G, Virone C, Grillo G, Barbiero 
A, Borsato L, Bonfanti F, Bonato D, Dona G, Barbato O, 
Falezza GC, Delaini C, Pedrazzoli R, Vincenzi P, Amadori 
F, Tomasi A, Bonifacio S, Gabrielli G, Quaglio GL, Covi 
MG, Stanzial M, Vettore L, Fazzini PM, Galvanini G, Sidoti 
G, Zennaro M, Marcon L, Faresin F, Beghelli G, Nalin G, 
Zavatteri G, Conti MP, Pasoli C, Pedron S, Girardello R, 
Cisno F, Zambotto FM, Festi G, Tommasini A, DeConti F, 
Cappellato G, Calvo MV, Barozzi E, Meloni GA, Tonin E, 
Santini GF, Martelli P, Piacentini I, Scagnelli M, Scarparo 
C. (1997) Aetiology and therapy of community-acquired 
pneumonia: a hospital study in northern Italy. Eur J Clin 
Pharmacol 51(6):437–443.
Franco L, Velo GP (1994) Role of nitric oxide in gastropro-
tection induced by copper-chelating drugs. Br J Pharmacol 
111:305.
Pasqualicchio M, Davies ME, Milanino R, Velo GP (1994) 
Efects of copper on proteoglycan synthesis in porcine car-
tilage synovium co-cultures. Br J Pharmacol 111:292.
Guglielmo L, Leone R, Moretti U, Conforti A, Velo GP. 
(1994). Antimicrobial drug utilization in hospitals in Italy 
and other European Countries. Infection 22:S176–S181.
Marrella M, Gasperini R, Rizzarelli, Velo GP, Milanino R 
(1994). Repeated oral zinc administration in the rat—anti-
inlammatory efect and changes in zinc and copper status 
in inlamed male and female animals. In: Metals in Biol-
ogy and Medicine, Vol 3. Proceedings of the Third Interna-
tional Symposium on Metal Ions in Biology and Medicine, 
3:571–575.
Marrella M, Guerrini F, Solero PL, Tregnaghi PL, Schena 
F, Velo GP (1993). Blood copper and zinc changes in run-
ners after a marathon. J Trace Elem Electrolytes Health Dis 
7(4):248–250.
Franco L, Erbetti I, Velo GP (1993). Synthesis of prostaglan-
din  E2 in rat liver. Pharmacol Res 28(4):367–374.
Milanino R, Frigo A, Bambara LM, Marrella M, Moretti U, 
Pasqualicchio M, Biasi D, Gasperini R, Mainenti L, Velo GP 
(1993). Copper and zinc status in rheumatoid arthritis: stud-
ies of plasma, erythrocytes, and urine, and their relationship 
to disease activity markers and pharmacological treatment. 
Clin Exp Rheumatol.11(3):271–281.
Franco L, Manara P, Erbetti I, Velo GP (1993). Anti-ulcer 
activity of carbenoxolone and ISF 3401 on  PGE2 release in 
rat gastric mucosa. Pharmacol Res;27(2):141–150.
Cristofori P, Terron A, Marella M, Moretti U, Pasqualicchio 
M, Velo GP, Milanino R (1992). Copper supplementation 
in the rat: preliminary observations on the clinical, hemato-
logical and histopathological proile. Agents Actions. Spec 
No:C118–C120.
Franco L, Velo GP. (1992) Efect of copper on gastric eicos-
anoid production. Pharmacol Res 25:240–241.
Milanino R, Marerella M, Moretti U, Pasqulicchio M, 
Gasperini R, Velo GP. (1992) Antiinlammatory activity 
of indomethacin in copper deicient rats. Pharmacol Res 
25:254–255.
Milanino R, Deganello A, Marrella M, Michielutti F, 
Moretto U, Pasqualicchio M, Tamassia G, Tato L, Velo 
GP. (1992). Oral zinc as initial therapy in Wilson’s-Dis-
ease—2 years of continuous treatment in a 10-year-old child. 
Acta Paediatrica 81(2):163–166.
Marrella M, Gasperini R, Milanino R, Moretti U, Pasqualic-
chio M, Gandini G, Travesini E, Vaccari R, Velo GP (1992). 
Inluence of sex and age on blood copper and zinc. Metal 
Ions Biol Med 2:426–427.
Fracasso ME, Franco L, Gasperini R, Velo GP (1992). 
NSAIDs on liver microsomal monooxygenase system and 
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Side-efects of anti-inlammatory drugs. 3:204–210.
Franco L, Erbetti I, Bacchini P, Velo GP (1992). The role of 
copper in preventing gastric damage by acetylsalicylic acid. 
In: Side efects of anti-inlammatory drugs, 3:359–362.
Milanino R, Frigo A, Marrella M, Bambara LM, Moretti 
U, Biasi D, Pasqualicchio M, Mainenti I, Velo GP (1992). 
Effect of NSAID therapy on plasma, whole blood cell 
(BC), and 24  h urine zinc in patients with rheumatoid 
arthritis (RA). In: Side-efects of anti-inlammatory drugs 
3:363–366.
Cavallini G, Brocco G, Bovo P, Frulloni L, DiFranceso V, 
Franco L, Velo GP, Psilogenis M, Nazzari M (1991). Efects 
of sulglytode on  PGE2 and gastric mucus in healthy volun-
teers. Acta Therapeutica 17(2):173–178.
Velo GP (1991) Pharmacologic rationale for the use of non-
steroidal anti-inlammatory agents in acute pain. Minerva 
Anestesiol. 57(11):1275–1276.
Conforti A, Caliceti P, Sartore L, Schiavon O, Veronese F, 
Velo GP (1991). Anti-inlammatory activity of monometh-
oxypolyethylene glycol superoxide dismutase on adjuvant 
arthritis in rats. Pharmacol Res 23(1):51–56.
Fracasso ME, Leone R, Cuzzolin L, Del Soldato P, Velo 
GP, Benoni G (1990). Indomethacin induced hepatic 
alterations in mono-oxygenase system and faecal Clostrid-
ium perfringens enterotoxin in the rat. Agents Actions 
31(3–4):313–316.
Gasperini R, Leone R, Velo GP, Fracasso ME (1990). The 
inhibition of hepatic microsomal drug metabolism in rats 
by non-steroidal anti-inlammatory drugs. Pharmacol Res 
22 Suppl 3:115–116.
Velo GP, Milanino R (1990). Nongastrointestinal adverse 
reactions to NSAID. J Rheumatol Suppl. 20:42–45.
Cuzzolin L, Caliceti P, Conforti A, Veronese FM, Velo GP, 
Benoni G (1990). Are bacterial toxins involved in arthritis 
induced in rats? Acta Physiol Hung 75 Suppl:71–72.
Cuzzolin L, Caliceti P, Conforti A, Veronese FM, Benoni 
G, Velo GP (1990). Intestinal bacterial lora and lesions in 
arthritic rats: efect of antiinlammatory drug. Acta Physiol 
Hung 75 Suppl:69–70.
Pasqualicchio M, Marrella M, Moretti U, Velo GP, Dega-
nello A, Tomelleri G, Milanino R (1990). Oral zinc sul-
phate treatment in Wilson’s disease. Acta Physiol Hung 75 
Suppl:233–234.
Franco L, Cavallini G, Brocco G, Orlandi PG, Manara P, 
Velo GP (1990). 40% but not 20% ethanol is an irritant able 
to evoke gastric release of  PGE2 in man. Acta Physiol Hung 
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Conforti A, Leone R, Moretti U, Sartori M, Velo GP (1990). 
Multicenter study of hospital adverse drug reactions. Acta 
Physiol Hung 75 Suppl:63–64.
Marrella M, Moretti U, Pasqualicchio M, Velo GP, Frigo 
A, Trevisani E, Bambara LM, Milanino R (1990). Plasma 
and total blood cell copper in rheumatoid arthritis. Agents 
Actions 29(1–2):120–121.
Fracasso ME, Leone R, Cuzzolin L, Del Soldata P, Velo 
GP, Benoni G. (1990) Indomethacin induced hepatic altera-
tions in mono-oxygenase system and fecal Clostridium-
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Marella M, Milanino R, Morelli U, Deganello A, Velo GP 
(1989) One year of oral zinc-sulphate therapy in a child with 
Wilson’s disease. Pharmacological Research 21(4):489–490.
Velo GP, Cavallini G, Brocco G, Orlandi PG, Franco 
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Milanino R, Marrella M, Moretti U, Velo GP, Deganello A, 
Ribezzo G, Tatò L. (1989) Oral zinc sulphate as primary 
therapeutic intervention in a child with Wilson disease. Eur 
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Moretti U, Cavallini G, Milanino R, Brocco G, Concari E, 
Riela A, Marrella M, Bertelli G, Pelle C, Scuro LA, Velo 
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